Influenza Vaccines for the World/Universal Influenza Vaccines (IVW/UIV) 2026

Influenza Vaccines for the World/Universal Influenza Vaccines (IVW/UIV) 2026 is organized by MEDICONmm and will be held from Oct 27 - 30, 2026 at National University Of Singapore, Singapore.

Conference Scope:
Influenza viruses cause seasonal epidemics as well as pandemics and are a significant concern for human health. Current influenza vaccines show efficacy when they are antigenically well matched to circulating strains. Seasonal influenza viruses undergo antigenic drift at a high rate and, therefore, current vaccines have to be reformulated and readministered on an annual basis. Mismatches between vaccine strains and circulating strains frequently occur, significantly decreasing vaccine efficacy. In addition, current seasonal influenza virus vaccines have limited efficacy against newly emerging pandemic viruses. A universal influenza virus vaccine that induces long-term protection against all influenza virus strains would abolish the need for annual readministration of seasonal influenza virus vaccines and would significantly enhance our pandemic preparedness.

IVW/UIV 2026 – this international forum will offer researchers an opportunity to discuss the characteristics of seasonal and universal influenza vaccines, their potential target antigens, and critical aspects to consider on the path to successfully developing effective seasonal and universal influenza virus vaccines.

This newly combined IVW/UIV 2026 international confernce world renowned experts in the field of influenza vaccines and related issues (adjuvants/delivery/vaccination strategies) to report on the latest data and trends associated with current and new influenza vaccines/technologies and their availability/delivery/implementation worldwide.